Milnacipran
Milnacipran
Milnacipran (/mɪlˈnæsɪpræn/) is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia or depression.
Etymology
The term "Milnacipran" is derived from the parts of the words: Mil (Millennium), na (Naphthyl), ci (Cyclopropane), and pran (Propanamine). It was developed by the pharmaceutical company Cypress Bioscience Inc.
Usage
Milnacipran is used to manage the symptoms of fibromyalgia and certain types of depression. It works by increasing the amounts of certain natural substances in the brain that help maintain mental balance and stop the movement of pain signals in the brain.
Related Terms
Side Effects
Common side effects of Milnacipran include nausea, headache, constipation, dizziness, and increased sweating. It can also cause high blood pressure. Therefore, regular monitoring of blood pressure is recommended while using this medication.
Precautions
Before starting treatment with Milnacipran, patients should inform their healthcare provider about any other medications they are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). They should also inform their healthcare provider about any major illnesses, especially kidney disease, liver disease, heart disease, or a history of seizures.
External links
- Medical encyclopedia article on Milnacipran
- Wikipedia's article - Milnacipran
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski